Digital Interpretative Diagnostic Cytopathology
Promotion of quality and education for all involved in screening and reporting Diagnostic Cytopathology.
PURPOSE OF PROGRAMME:
Provide excellent and appropriate cytological examples to enable individual competency assessment and feedback, and to promote education within Diagnostic Cytopathology
MATERIAL PROVIDED: On-line assessment of whole slide images of diagnostic cytopathological material
DISTRIBUTIONS PER YEAR: 2
SAMPLES PER DISTRIBUTION: 12
FREQUENCY OF DISTRIBUTION: Bi Annually
PROGRAMME OF ANALYSIS:
Digital Interpretative Web Based Schemes
Individual reports following each distribution • A detailed summary of the scoring against clinical diagnosis • Frequency charts of submission scores, illustrating the distribution of participant scores for each personnel category and the mean scores Generic Distribution Report Participation Certificate
Performance is scored by a Specialist Advisory Group of expert biomedical scientists, advanced practitioners, clinical scientists and consultant pathologists, with extensive knowledge and experience in the field of cellular pathology.
Issues with performance managed locally by UK NEQAS CPT
Cellular Pathology Technique (CPT)
UK NEQAS Cellular Pathology Technique (CPT) is an international organisation providing a comprehensive range of EQA and proficiency testing programmes for all aspects of tissue diagnostics. The result of many years of evolution and development in the field of Cellular Pathology Technical EQA and proficiency testing, UK NEQAS CPT provide a secure and established set of Schemes, with a first-class reputation and an extensive and stable participant base. UK NEQAS CPT has been successfully running for 30 years, encompassing EQA and proficiency testing programmes, education and support for all practicing clinical and non-clinical pathology based facilities in the UK and across the globe. Accredited to International Standards, UK NEQAS CPT is UKAS accredited proficiency testing provider No. 8268. Our aim is to ensure that all our participants receive high quality, appropriate, clinically relevant and challenging samples that fully meet their facility’s requirements; and that our assessment of those samples is consistent, carried out by qualified assessors, graded and anonymously compared and peer reviewed. Our participating laboratories in over 40 countries, collectively submit over 20, 000 patient samples per annum, to be graded by our experts, to guide and to ensure best practice and gold standard results for participating laboratories and patient care.